info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

BRIC Diabetes Treatment Prevention Companies

The term "BRIC" refers to a grouping of major emerging national economies: Brazil, Russia, India, and China. These countries are known for their rapid economic development and represent significant markets for various industries, including healthcare. Diabetes treatment and prevention in these countries involve a range of companies that offer pharmaceuticals, medical devices, and innovative solutions.

BRIC Diabetes Treatment and Prevention Key Companies

 

Latest BRIC Diabetes Treatment and Prevention Companies Update


 


Dec 2023Novo Nordisk Launched their FlexTouch® insulin pen with an improved needle design in all BRIC countries, enhancing patient comfort and injection experience.Partnered with local healthcare organizations to improve insulin access and diabetes education in rural areas.


Eli Lilly and Company Received regulatory approval for their Trulicity® GLP-1 agonist in additional BRIC markets, expanding access to this long-acting medication.Collaborated with digital health startups to develop AI-powered tools for diabetes management and patient support.


Sanofi S.A. Introduced their SoloStar® pen with pre-filled insulin cartridges in different insulin types across BRIC countries, offering convenience and flexibility for patients.Focused on developing affordable insulin formulations and pricing strategies for wider accessibility.


Medtronic Launched their MiniMed™ 670G system with integrated insulin pen connectivity in India, allowing for automated insulin delivery based on continuous glucose monitoring data.Partnered with government agencies to provide diabetes management technologies and training programs in remote regions.


Johnson & Johnson Expanded access to their Canagliflozin SGLT-2 inhibitor medication in Brazil and Russia, offering a new treatment option for diabetes management.Invested in research and development of novel diabetes medications and technologies tailored for the specific needs of BRIC populations.


List of BRIC Diabetes Treatment and Prevention Key Companies in the Market



  • Abbott Laboratories (U.S)

  • Bayer AG (Germany)

  • Eli Lily & Company (U.S)

  • Medtronic (U.S)

  • AstraZeneca Plc. (U.K)

  • Lifescan (U.S)

  • Terumo Medical Corporation (Japan)

  • Roche Holding AG (Switzerland)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.